Hepatitis B Virus

New hepatitis B virus research from X. Guennoc et al outlined

Published in Hepatitis Weekly, August 24th, 2009

In this recently published study, investigators in Brest, France conducted a study "To evaluate the seroprevalence of hepatitis B (HBV) and C (HCV) in patients living ill France with recent-onset polyarthritis suggesting rheumatoid arthritis. The 813 patients in the ESPOIR cohort were screened for anti-HCV antibodies and HBs antigen."

"Seroprevalence was 0.86% for HCV (n = 7) and 0. 12% for HBV (n = 1). HCV-related arthritis was diagnosed in 4 (0.5%) patients; no patient had HBV-related arthritis. HCV-seropositive patients had significantly higher transaminase levels (ALAT, 41.5 IU vs 23.2 IU. p = 0.02 and ASAT, 39.2 IU vs 21.8 IU, p = 0.001) but only 2 patients had...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2009-08-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry